“Buyout firm Bain Capital has reached an agreement to buy pharmaceutical joint-venture of Dutch chemicals firm Royal DSM NV and China’s Sinochem Group,” reported Bloomberg. “Singapore-based DSP develops and sells antibiotics, statins and anti-fungals as well as pharmaceutical ingredients, according to its website. It has manufacturing sites in countries from China and India to Egypt, the Netherlands and the U.S.”
AZB & Partners advised
Primary jurisdiction of deal:
2018-06-29
Deal value: Rs 4600 crore ($681m)
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.